المؤلفون: Shira Zelber-Sagi, Rebecca Dorner, Giulio Marchesini, Marko Korenjak, Christos Lionis, Jeffrey V. Lazarus, Sven Francque, Achim Kautz, Luca Busetto, José Willemse, G. Koek, Dror Dicker, Kate Hallsworth, Shlomo Vinker, Gema Frühbeck, Euan Woodward, Mehmet Ungan, Juan M. Mendive, Martine Walmsley

المساهمون: Francque, Sven M, Marchesini, Giulio, Kautz, Achim, Walmsley, Martine, Dorner, Rebecca, Lazarus, Jeffrey V, Zelber-Sagi, Shira, Hallsworth, Kate, Busetto, Luca, Frühbeck, Gema, Dicker, Dror, Woodward, Euan, Korenjak, Marko, Willemse, José, Koek, Gerardus H, Vinker, Shlomo, Ungan, Mehmet, Mendive, Juan M, Lionis, Christos, Interne Geneeskunde, MUMC+: MA Maag Darm Lever (9), RS: NUTRIM - R2 - Liver and digestive health

المصدر: JHEP Reports
JHEP Reports, Vol 3, Iss 5, Pp 100322-(2021)
JHEP Reports, 3(5):100322. Elsevier BV

مصطلحات موضوعية: NASH, non-alcoholic steatohepatiti, Y GASTRIC BYPASS, Disease, RC799-869, PLACEBO-CONTROLLED TRIAL, LIFE-STYLE MODIFICATION, cardiovascular disease, LDL, low-density lipoprotein, HEPATOCELLULAR-CARCINOMA, non-invasive test, T2D, GLP-1 RAs, glucagon-like receptor 1 agonists, European Association for the Study of Obesity, HCC, Gastroenterology, NASH, specific, Diseases of the digestive system. Gastroenterology, CAP, controlled attenuation parameter, CT, computed tomography, FXR, ASH, alcoholic steatohepatitis, GP, non-alcoholic steatohepatitis, GLP-1 RAs, glucagon-like receptor 1 agonist, LDL, low-density lipoproteins, medicine.medical_specialty, HDL, achievable, NASH, non-alcoholic steatohepatitis, T2D, type 2 diabetes, high-density lipoprotein, CVD, cardiovascular disease, LDL, Patient Guideline, Quality of life (healthcare), FXR, farnesoid X receptor, NAFLD, low-density lipoproteins, GP, general practitioner, NAFL, non-alcoholic fatty liver, FIB-4, fibrosis-4 index, Intensive care medicine, computed tomography, Guideline, medicine.disease, T1D, type 1 diabete, digestive system diseases, NIT, Human medicine, farnesoid X receptor, type 1 diabetes, BMI, body mass index, EASL, European Association for the Study of the Liver, Placebo-controlled study, Chronic liver disease, GLP-1 RAs, QUALITY-OF-LIFE, alcoholic steatohepatitis, European Association for the Study of Diabetes, EASD, European Association for the Study of Diabetes, Immunology and Allergy, magnetic resonance imaging, NASH Clinical Research Network, ALD, alcohol-related or alcoholic liver disease, Disease management (health), glucagon-like receptor 1 agonists, EASO, European Association for the Study of Obesity, NASH CRN, NASH Clinical Research Network, ASH, alcoholic steatohepatiti, Fatty liver, timely, hepatocellular carcinoma, CVD, magnetic resonance elastography, MRE, NAFL, FIB-4, non-alcoholic fatty liver, type 2 diabetes, T1D, type 1 diabetes, CAP, controlled attenuation parameter, CT, European Association for the Study of the Liver, MRI, fibrosis-4 index, NAFLD, non-alcoholic fatty liver disease, EASD, HDL, high-density lipoprotein, UNITED-STATES, ASH, body mass index, EASL, measurable, BMI, NIT, non-invasive test, Internal Medicine, medicine, NASH CRN, HEPATIC STEATOSIS, HCC, hepatocellular carcinoma, MRE, magnetic resonance elastography, MRI, magnetic resonance imaging, SMART, specific, measurable, achievable, relevant, timely, Disease burden, BARIATRIC SURGERY, Hepatology, SMART, business.industry, SERUM ALANINE AMINOTRANSFERASE, non-alcoholic fatty liver disease, PHYSICAL-ACTIVITY, alcohol-related or alcoholic liver disease, EASD, European Association for the Study of Diabete, EASO, ALD, general practitioner, relevant, T1D, business

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc5e84bfe19b52d5e0324b299615b0e1Test
https://pubmed.ncbi.nlm.nih.gov/34693236Test

المؤلفون: Lucia Parlati, Catherine Postic, Marion Régnier, Hervé Guillou

المساهمون: LESUR, Hélène, Impact du métabolisme des acides gras des tissus adipeux et du foie sur l'insulinorésistance - - HepAdialogue2017 - ANR-17-CE14-0015 - AAPG2017 - VALID, Institut Cochin (IC UM3 (UMR 8104 / U1016)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université Catholique de Louvain = Catholic University of Louvain (UCL), ToxAlim (ToxAlim), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Ecole Nationale Vétérinaire de Toulouse (ENVT), Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Ecole d'Ingénieurs de Purpan (INPT - EI Purpan), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Toxicologie Intégrative & Métabolisme (ToxAlim-TIM), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)-Université Toulouse III - Paul Sabatier (UT3), Lucia Parlati and Catherine Postic received funding from the French association for the study of the liver (AFEF). Catherine Postic and Herve Guillou received funding from the Agence Nationale de la Recherche (ANR-17-CE14-0015Hepadialogue)., ANR-17-CE14-0015,HepAdialogue,Impact du métabolisme des acides gras des tissus adipeux et du foie sur l'insulinorésistance(2017), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Paris (UP)

المصدر: JHEP Reports
JHEP Reports Innovation in Hepatology
JHEP Reports Innovation in Hepatology, 2021, 3 (6), pp.100346. ⟨10.1016/j.jhepr.2021.100346⟩
JHEP Reports Innovation in Hepatology, Elsevier, 2021, 3 (6), pp.100346. ⟨10.1016/j.jhepr.2021.100346⟩

مصطلحات موضوعية: HFD, high-fat diet, SREBP-1c, [SDV]Life Sciences [q-bio], Disease, Review, ACC, acetyl-CoA carboxylase, ASK1, apoptosis signal-regulating kinase 1, Chronic liver disease, Bioinformatics, ChREBP, carbohydrate responsive element–binding protein, PPARα, NEFA, TNF-α, tumour necrosis factor-α, 0302 clinical medicine, Fibrosis, Immunology and Allergy, Medicine, IL-, interleukin, VLDL, very low-density lipoprotein, 0303 health sciences, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, NEFA, non-esterified fatty acid, Fatty liver, Gastroenterology, NASH, lipotoxicity, FAS, fatty acid synthase, animal models, 3. Good health, [SDV] Life Sciences [q-bio], PY, persons/years, Lipotoxicity, FXR, Saturated fatty acid, JNK, c-Jun N-terminal kinase, 030211 gastroenterology & hepatology, LXR, CAP, controlled attenuation parameter, HSL, hormone-sensitive lipase, HSC, hepatic stellate cells, GGT, gamma glutamyltransferase, NAFLD, non-alcoholic fatty liver disease, ChREBP, NASH, non-alcoholic steatohepatitis, SFA, saturated fatty acid, TCA, tricarboxylic acid, Phf2, histone demethylase plant homeodomain finger 2, digestive system, 03 medical and health sciences, glucotoxicity, FXR, farnesoid X receptor, NAFLD, FFA, free fatty acid, Internal Medicine, RCT, randomised controlled trial, Liver X receptor, PPARa, 030304 developmental biology, FGF21, fibroblast growth factor-21, MCD, methionine- and choline-deficient, HVPG, hepatic venous pressure gradient, Hepatology, business.industry, PUFAs, polyunsaturated fatty acids, nutritional and metabolic diseases, TLR4, Toll-like receptor 4, SCD1, stearoyl-CoA desaturase-1, medicine.disease, digestive system diseases, PPARα, peroxisome proliferator-activated receptor-α, SREBP-1c, sterol regulatory element–binding protein-1c, Steatosis, LXR, liver X receptor, business, HCC, hepatocellular carcinoma, MUFA, monounsaturated fatty acids, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba31673956635c337dc60791ff712432Test
https://pubmed.ncbi.nlm.nih.gov/34667947Test

المؤلفون: Linda Henry, Zobair M. Younossi

المصدر: JHEP Reports

مصطلحات موضوعية: medicine.medical_specialty, NAFLD, non-alcoholic fatty liver disease, Cirrhosis, STAT3, signal transducer and activator of transcription 3, NASH, non-alcoholic steatohepatitis, Context (language use), Disease, Type 2 diabetes, Review, CVD, cardiovascular disease, Gastroenterology, digestive system, ELF, enhanced liver fibrosis, PDGF, platelet-derived growth factor, Internal medicine, Epidemiology, Internal Medicine, Immunology and Allergy, Medicine, awareness, FIB-4, fibrosis-4, ALD, alcohol-related liver disease, neoplasms, Hepatology, business.industry, cirrhosis, Fatty liver, nutritional and metabolic diseases, non-cirrhosis, medicine.disease, Obesity, VEGF, vascular endothelial growth factor, digestive system diseases, natural history, Hepatocellular carcinoma, surveillance, business, HCC, hepatocellular carcinoma, TNF, tumour necrosis factor-α

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48a4964dc0d86470071e38394d6df7fbTest
https://pubmed.ncbi.nlm.nih.gov/34189448Test

المؤلفون: Syed Tasleem, Umar Hayat, Saba Afroz, Ahmed Haris, Hayrettin Okut, Ali A. Siddiqui

المصدر: Annals of Hepatology, Vol 20, Iss, Pp 100254-(2021)

مصطلحات موضوعية: Liver Cirrhosis, medicine.medical_specialty, Specialties of internal medicine, Drinking Behavior, Disease, Chronic liver disease, Gastroenterology, NAFLD (non-alcoholic fatty liver disease), Coffee, NASH (Non-alcoholic steatohepatitis), 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Non-alcoholic Fatty Liver Disease, Internal medicine, Caffeine, Epidemiology, medicine, Humans, Hepatology, business.industry, Fatty liver, Confidence interval, nutritional and metabolic diseases, General Medicine, medicine.disease, digestive system diseases, Relative risk, chemistry, RC581-951, 030220 oncology & carcinogenesis, Meta-analysis, 030211 gastroenterology & hepatology, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9db1203a30b676744792d706528112a5Test
https://pubmed.ncbi.nlm.nih.gov/32920163Test

المؤلفون: Anneleen Remmerie, Liesbet Martens, Charlotte L. Scott

المصدر: Frontiers in Endocrinology
FRONTIERS IN ENDOCRINOLOGY
Frontiers in Endocrinology, Vol 11 (2020)

مصطلحات موضوعية: 0301 basic medicine, POLARIZATION, Endocrinology, Diabetes and Metabolism, ADIPOCYTE DEATH, Adipose tissue, 030209 endocrinology & metabolism, Inflammation, Context (language use), Disease, Review, Biology, liver, lcsh:Diseases of the endocrine glands. Clinical endocrinology, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, INFLAMMATION, Non-alcoholic Fatty Liver Disease, LOCAL PROLIFERATION, medicine, Medicine and Health Sciences, Macrophage, Animals, Humans, NASH (non-alcoholic steatohepatitis), Obesity, Metabolic Syndrome, lcsh:RC648-665, NONALCOHOLIC STEATOHEPATITIS, HEPATIC RECRUITMENT, Macrophages, Fatty liver, NICHE, Biology and Life Sciences, single-cell, medicine.disease, macrophages, adipose tissue, 030104 developmental biology, Immunology, CELLS, Metabolic syndrome, medicine.symptom, DEPLETION, Inflammation Mediators, heterogeneity, SPI-C, non-alcoholic fatty liver disease (NAFLD)

وصف الملف: text/plain

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03d4176e5893622d3bdbf0e1629d38caTest
https://pubmed.ncbi.nlm.nih.gov/32411096Test

المؤلفون: Jérôme Boursier, Emmanuel Tsochatzis

المساهمون: Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)

المصدر: JHEP Reports Innovation in Hepatology
JHEP Reports Innovation in Hepatology, Elsevier, 2021, 3 (2), pp.100219. ⟨10.1016/j.jhepr.2020.100219⟩
JHEP Reports

مصطلحات موضوعية: Cirrhosis, Cost effectiveness, [SDV]Life Sciences [q-bio], NICE, National Institute of Clinical Excellence, Nice, Review, AST, aspartate aminotransferase, Disease, Patient pathway, ELF, enhanced liver fibrosis, 0302 clinical medicine, Immunology and Allergy, Medicine, NFS, NAFLD fibrosis score, ALD, alcohol-related liver disease, ComputingMilieux_MISCELLANEOUS, computer.programming_language, 0303 health sciences, NAS, NAFLD activity score, Case-finding, Fatty liver, Gastroenterology, Awareness, Primary care, TE, transient elastography, 3. Good health, Screening, FIB-4, 030211 gastroenterology & hepatology, Elastography, NAFLD, non-alcoholic fatty liver disease, medicine.medical_specialty, NASH, non-alcoholic steatohepatitis, Liver fibrosis, QALY, quality-adjusted life year, 03 medical and health sciences, ALT, alanine aminotransferase, Type 2 diabetes mellitus, NIT, non-invasive test, Internal Medicine, GP, general practitioner, FIB-4, fibrosis-4, Intensive care medicine, 030304 developmental biology, Hepatology, business.industry, Type 2 Diabetes Mellitus, T2DM, type 2 diabetes mellitus, medicine.disease, Quality-adjusted life year, Cost-effectiveness, Transient elastography, business, computer

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::998a5dc5ae8854bb83716af6e6873dc7Test
https://doi.org/10.1016/j.jhepr.2020.100219Test

المؤلفون: Nikolaos Perakakis, Konstantinos Stefanakis, Christos S. Mantzoros

المصدر: Metabolism

مصطلحات موضوعية: Proteomics, HCC, Hepatocellular carcinoma, Cirrhosis, SWE, Shear wave elastography, Endocrinology, Diabetes and Metabolism, TM6SF2, Transmembrane 6 superfamily member 2, Disease, CK-18, Cytokeratin-18, GCKR, Glucokinase regulatory protein, HDACis, HDAC inhibitors, transcriptomics, HSI, Hepatic Steatosis index, 0302 clinical medicine, Endocrinology, DAG, Diacylglycerol, EPA, Eicosapentanoic acid, MRI-PDFF, Magnetic resonance imaging derived proton density fat fraction, PE, Phosphatidylethanolamine, lncRNA, Long noncoding RNA, CAP, Controlled attenuation parameter, IgG, Immunoglobulin G, NASH, NAFLD, Non-alcoholic fatty liver disease, Genomics, TGF, Transforming growth factor, DHA, Docosahexaenoic acid, GRS, Genetic risk score, CRP, C-reactive protein, DHEA, Dehydroepiandrosterone, DNMTis, DNA methylation inhibitors, medicine.medical_specialty, PDGF, Platelet-derived growth factor, NASH, non-alcoholic steatohepatitis, DZNep, 3-deazaneplanocin A, tRNA, Transport RNA, PLA2, Phospholipase A2, digestive system, Article, TG, Triglyceride, 03 medical and health sciences, IL-32, Interleukin 32, AUROC, Area under the receiver operator characteristics, Humans, Metabolomics, MS, Mass Spectrometry, SPM, Specialized pro-resolving mediator, nutritional and metabolic diseases, TOF, Time-of-flight, medicine.disease, Omics, AST, Aspartate transaminase, PNPLA3, Patatin-like phospholipase domain-containing-3, digestive system diseases, NAFL, Non-alcoholic fatty liver, 030104 developmental biology, FXR, Farnesoid X receptor, PTPRE, protein-tyrosine phosphatase epsilon, Steatohepatitis, IGF, Insulin growth factor, ROS, Reactive oxygen species, ACC, Acetyl-coA carboxylase, Liver Cirrhosis, 0301 basic medicine, F#, Fibrosis (score), LPE, Lysophosphatidylethanolamine, LSM, Liver stiffness measurement, IL-32, Interleukin-32, VCTE, Vibration-controlled transient elastography, Bioinformatics, glycomics, HAT, Histone acetyltransferase, Non-alcoholic Fatty Liver Disease, APRI, Aspartate aminotransferase to platelet ratio index, steatosis, FADS, Fatty acid desaturase, circRNA, Circular RNA, NFS, NAFLD fibrosis score, PUFA, Polyunsaturated fatty acid, SNP, Single nucleotide polymorphism, NAS, NAFLD activity score, medicine.diagnostic_test, Fatty liver, AA, Arachidonic acid, IL-10, Interleukin-10, SFA, Saturated fatty acids, Liver biopsy, LPC, Lysophosphatidylcholine, FIB-4, Fibrosis-4 score, IGFBP, Insulin growth factor binding protein, ApoE, Apolipoprotein E, GGT, Gamma-glutamyltransferase, ChREBP, Carbohydrate, responsive element-binding protein, MUFA, Monounsaturated fatty acid, PC, Phosphatidylcholine, 030209 endocrinology & metabolism, PPAR, Peroxisome proliferator-activated receptor, HFD, High fat diet, Internal medicine, medicine, Animals, MetS, Metabolic syndrome, IL-6, Interleukin-6, MRE, magnetic resonance elastography, SIRT, Sirtuin, SELDI, Surface-enhanced laser desorption/ionization, BMI, Body mas index, business.industry, HDAC, Histone deacetylase, WC, Waist circumference, ALT, Alanine aminotransferase, CHI3L1, Chitinase 3 Like 1, FFA, Free fatty acids, GWAS, Genome - wide association studies, epigenomics, HSD17B13, 17-b retinol dehydrogenase 13, miR, Micro RNA, lipidomics, 1H-MRS, Magnetic resonance imaging and proton spectroscopy, MBOAT7, Membrane bound O-acyltransferase domain-containing 7, Steatosis, business, OR, Odds ratio, T2DM, Type 2 Diabetes Mellitus

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29bb96bcd7fb056ebf01eec2214ad114Test
https://doi.org/10.1016/j.metabol.2020.154320Test

المؤلفون: Yemi Oluboyede, Gulnar Fattakhova, Lorraine McSweeney, Luke Vale, Lynda C. Doward, Fiona Beyer, Clifford A. Brass, Quentin M. Anstee, Matthew Breckons, Laura Ternent, Maria-Magdalena Balp, Arun J. Sanyal

المصدر: JHEP Reports
JHEP Reports, Vol 2, Iss 3, Pp-(2020)

مصطلحات موضوعية: medicine.medical_treatment, Disease, Liver disease, 0302 clinical medicine, Immunology and Allergy, 030212 general & internal medicine, Non-alcoholic steatohepatitis, education.field_of_study, Gastroenterology, PRO, patient-reported outcome, LDSI, liver disease symptom index, 3. Good health, health-related quality of life, Cirrhosis, 030211 gastroenterology & hepatology, Patient-reported outcome, SF-36, short form health profile 36, Research Article, FDA, United States Food and Drug Administration, RI, researcher interpretation, HRQoL, health-related quality of life, NAFLD, non-alcoholic fatty liver disease, medicine.medical_specialty, SF-36, NASH, non-alcoholic steatohepatitis, Population, liver, digestive system, Support group, MS, multiple sclerosis, 03 medical and health sciences, Quality of life (healthcare), NAFLD, PHAQ, patient-reported outcome measurement information system health assessment questionnaire, Internal Medicine, medicine, NAFL, non-alcoholic fatty liver, CLDQ, chronic liver disease questionnaire, lcsh:RC799-869, Intensive care medicine, education, patient-reported outcome measures, Hepatology, business.industry, nutritional and metabolic diseases, medicine.disease, QoL, quality of life, Mental health, digestive system diseases, FIS, fatigue impact scale, PROM, patient-reported outcome measure, EMA, European Medicines Agency, COSMIN, The COnsensus-based Standards for the selection of health Measurement INstruments, lcsh:Diseases of the digestive system. Gastroenterology, business, LDQoL, liver disease quality of life questionnaire

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee751f2b6ffd99b10142118b951f0fcdTest
https://doi.org/10.1016/j.jhepr.2020.100099Test

المؤلفون: Muhammad Ibrahim, Maryam Abimbola Mikail, Idris Adewale Ahmed, Rozana Othman, Mohammad Rais Mustafa

المصدر: Saudi Journal of Biological Sciences, Vol 26, Iss 7, Pp 1519-1524 (2019)
Saudi Journal of Biological Sciences

مصطلحات موضوعية: 0106 biological sciences, 0301 basic medicine, medicine.medical_specialty, NAFLD, non-alcoholic fatty liver disease, Weight loss, Cirrhosis, NASH, non-alcoholic steatohepatitis, EASL, European Association for the Study of the Liver, DHA, docosahexaenoic acid, Disease, 01 natural sciences, Gastroenterology, digestive system, Article, 03 medical and health sciences, Liver disease, Internal medicine, EASD, European Association for the Study of Diabetes, medicine, DDT, dichlorodiphenyltrichloroethane, EASO, European Association for the Study of Obesity, Exercise, lcsh:QH301-705.5, business.industry, Fatty liver, nutritional and metabolic diseases, medicine.disease, EPA, eicosapentaenoic acid, Lifestyle, digestive system diseases, Diet, AASLD, American Association for the Study of Liver Diseases, 030104 developmental biology, lcsh:Biology (General), Hepatocellular carcinoma, ALA, alpha-linolenic acid, Steatosis, medicine.symptom, Steatohepatitis, General Agricultural and Biological Sciences, business, 010606 plant biology & botany

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f2047a39f739379090519c0d5b90777Test
https://pubmed.ncbi.nlm.nih.gov/31762620Test

المؤلفون: George Boon-Bee Goh, Ruth Sargent, Srinivasan Dasarathy, Jaividhya Dasarathy, Aynur Unalp-Arida, Achuthan Sourianarayanane, Rish K. Pai, Arthur J. McCullough, Mangesh R. Pagadala, Carol Hawkins, Amer Khiyami, Lisa Yerian

المصدر: BBA Clinical

مصطلحات موضوعية: Very low-density lipoprotein, BMI, body mass index, LDL, low density lipoprotein cholesterol, INR, international normalised ratio, AST, aspartate aminotransferase, Disease, Gastroenterology, Fibrosis score, NFS, NAFLD fibrosis score, DM, type 2 diabetes mellitus, apoB-100, apolipoprotein B-100, NAS, NAFLD activity score, TGs, triglycerides, Fatty liver, Regular Article, Non-diabetic, ACE-I, angiotensin-converting enzyme-inhibitor, 3. Good health, ARB, angiotensin receptor blocker, Molecular Medicine, Non diabetic, NAFLD, non-alcoholic fatty liver disease, medicine.medical_specialty, NASH, non-alcoholic steatohepatitis, NASH CRN, Non-alcoholic Steatohepatitis Clinical Research Network, ORs, odd ratios, digestive system, VLDL, very-low-density lipoproteins, Pathology and Forensic Medicine, ER, endoplasmic reticulum, Diabetic, ALT, alanine aminotransferase, NAFLD, Physiology (medical), Diabetes mellitus, Internal medicine, medicine, FFAs, free-fatty acids, In patient, Chol, total cholesterol, ALP, alkaline phosphatase, business.industry, SDs, standard deviations, nutritional and metabolic diseases, Non alcoholic, NAFLD fibrosis score, medicine.disease, CIs, confidence intervals, digestive system diseases, HDL, high density lipoprotein cholesterol, Endocrinology, HOMA-IR, Homeostatic model assessment—insulin resistance, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a7eb9348140df9a8c541a554f5a132dTest